| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 01/08/2009 | WO2009004430A1 N-benzyl oxazolidinones and related heterocycleic compounds as potentiators of glutamate receptors |
| 01/08/2009 | WO2009004383A2 Aza-bicyclohexane compounds useful as anticoagulants |
| 01/08/2009 | WO2009004382A2 3-spiropyrimidinetrione-quinoline derivatives and their use as antibacterial agents |
| 01/08/2009 | WO2009004379A1 Novel compounds 951: a biphenyloxypropanoic acid as crth2 modulator and intermediates |
| 01/08/2009 | WO2009004374A1 Process for introduction of hydroxyethoxy side chain in bosentan |
| 01/08/2009 | WO2009004356A1 Phthalazinone derivatives as inhibitors of parp-1 |
| 01/08/2009 | WO2009004339A2 Modulation of reactive oxygen species in the treatment of respiratory infection |
| 01/08/2009 | WO2009004329A1 9h-pyrimido[4,5-b]indoles, 9h-pyrido[4',3':4,5]pyrrolo[2,3-d]pyridines, and 9h-1,3,6,9-tetraaza-fluorenes as chk1 kinase function inhibitors |
| 01/08/2009 | WO2009004322A2 Derivatives of nystatin and their use as antifungal agents |
| 01/08/2009 | WO2009004302A1 Use of tetrahydrocannabinol and/or cannabidiol for the treatment of inflammatory bowel disease |
| 01/08/2009 | WO2009004188A2 Direct dissolution of docetaxel in a solvent in polysorbate 80 |
| 01/08/2009 | WO2009004153A1 Method for producing families of galacturonic acid oligomers and use thereof |
| 01/08/2009 | WO2009004152A2 Use of a composition of oligomers of galacturonic acid as an agent for inhibiting degradation of collagen |
| 01/08/2009 | WO2009004146A2 Novel herbimycin a analogue derivatives, compositions containing same and use thereof |
| 01/08/2009 | WO2009004114A1 A method of treating amblyopia |
| 01/08/2009 | WO2009004085A2 Dsrna for treating viral infection |
| 01/08/2009 | WO2009004082A2 Anticonvulsive pharmaceutical compositions |
| 01/08/2009 | WO2009004071A1 Use of piperine and derivatives thereof for the therapy of neurological conditions |
| 01/08/2009 | WO2009004064A1 Process for preparing telmisartan |
| 01/08/2009 | WO2009004063A1 Silicon containing compounds and their use as anti-inflammatory agents |
| 01/08/2009 | WO2009004060A1 Novel triazine compounds for treatment of cancer |
| 01/08/2009 | WO2009004038A2 Pirenzepine and derivatives thereof as anti-amyloid agents |
| 01/08/2009 | WO2009003999A2 Chemical compounds |
| 01/08/2009 | WO2009003998A2 Antiproliferative compounds based on 5-membered heterocycles |
| 01/08/2009 | WO2009003997A1 Imidazo [1, 2-c] pyrimidin-2-ylmethylpiperidines as orexin receptor antagonists |
| 01/08/2009 | WO2009003993A1 Piperidine derivatives useful as orexin receptor antagonists |
| 01/08/2009 | WO2009003991A1 Composition containing at least one nutritive, at least one disinfecting or decontaminating, and/or at least one protease-inhibiting active compound and/or active compound complex |
| 01/08/2009 | WO2009003970A1 Targeting diazo prodrugs for the treatment of gastrointestinal diseases |
| 01/08/2009 | WO2009003965A1 Injectable veterinary composition with anti-prolactin activity |
| 01/08/2009 | WO2009003951A1 Nanoassembled complexes of nucleic acids, avidin and polymers, use and preparation thereof |
| 01/08/2009 | WO2009003935A1 Vaginal odorants |
| 01/08/2009 | WO2009003921A1 Novel pyrazole derivatives useful as potassium channel modulators |
| 01/08/2009 | WO2009003911A1 Thiophene-imidazopyridines |
| 01/08/2009 | WO2009003899A1 Synergistic combination of proanthocyanidins, gamma-tocotrienol and niacin |
| 01/08/2009 | WO2009003878A1 Method for the preparation of mycophenolate mofetil |
| 01/08/2009 | WO2009003868A2 2 -imidazolines having a good affinity to the trace amine associated receptors (taars) |
| 01/08/2009 | WO2009003867A1 4-imidazolines and their use as antidepressants |
| 01/08/2009 | WO2009003861A1 Imidazole derivatives as ccr2 receptor antagonists |
| 01/08/2009 | WO2009003831A1 Food composition comprising p-coumaric acid and its use to control blood pressure |
| 01/08/2009 | WO2009003798A1 Food composition comprising trans-resveratrol and its use to control blood pressure |
| 01/08/2009 | WO2009003724A1 Tolterodine bead |
| 01/08/2009 | WO2009003719A2 Indane-amine derivatives, their preparation and use as medicaments |
| 01/08/2009 | WO2009003711A2 Stereoisomers of tricyclodecan-9-yl-xanthogenate |
| 01/08/2009 | WO2009003681A1 Dpp-iv inhibitors |
| 01/08/2009 | WO2009003669A2 Pyrido(3,2-d)pyrimidines and pharmaceutical compositions useful for medical treatment |
| 01/08/2009 | WO2009003656A1 Cyclodextrin-based nanosponges as a vehicle for antitumoral drugs |
| 01/08/2009 | WO2009003631A1 Combinations of vasoactive substances with estrogens and their use in the treatment of female sexual dysfunctions |
| 01/08/2009 | WO2009003625A1 Aminophenoxazinone as an anti-tumour and anti-inflammatory agent |
| 01/08/2009 | WO2009003595A2 Macrolactone derivatives |
| 01/08/2009 | WO2009003356A1 A pharmaceutical composition for decreasing the area of myocardial infarct and application thereof |
| 01/08/2009 | WO2009003307A1 Phthiobuzonum derivatives and preparation, pharmaceutical composition and use thereof |
| 01/08/2009 | WO2009003289A1 Small molecule correctors of deltaf508 cftr trafficking |
| 01/08/2009 | WO2009003274A1 Susceptibility gene for inflammatory bowel disease |
| 01/08/2009 | WO2009003255A1 Pharmaceutical compositions comprising semicarbazones and thiosemicar-bazones and method for treating inflammatory, painful and febrile conditions and preventing signs and symptoms |
| 01/08/2009 | WO2009003229A1 2-substituted isoflavonoid compounds, medicaments and uses |
| 01/08/2009 | WO2009003226A1 Treatment or prophylaxis or neurological or neuropsychiatric disorders via ocular administration |
| 01/08/2009 | WO2009003211A1 Treatment of rheumatoid arthritis |
| 01/08/2009 | WO2008142720A3 Quinazolin-oxime derivatives as hsp90 inhibitors |
| 01/08/2009 | WO2008142693A3 Regulation of myelination by nectin-like (necl) molecules |
| 01/08/2009 | WO2008141462A9 Novel case of renin inhibitors |
| 01/08/2009 | WO2008139402A3 A method of inhibiting hiv replication |
| 01/08/2009 | WO2008139123A3 Pharmaceutical or cosmetic preparations for topical and/or parenteral application, preparation methods thereof and use of same |
| 01/08/2009 | WO2008138621A3 Synthesis of aminocyclopentane carboxylic acids |
| 01/08/2009 | WO2008138079A3 Use of nucleoside derivatives as anti-koi herpes virus in fish |
| 01/08/2009 | WO2008137779A3 Novel macrocyclic inhibitors of hepatitis c virus replication |
| 01/08/2009 | WO2008134474A3 Compositions and methods including cell death inducers and procaspase activation |
| 01/08/2009 | WO2008133734A3 Method and compositions for treating hiv infections |
| 01/08/2009 | WO2008128009A3 Aminopyrimidines useful as kinase inhibitors |
| 01/08/2009 | WO2008127275A3 Pyrrolinone compounds as inhibitors of bacterial peptidyl trna hydrolase and uses thereof |
| 01/08/2009 | WO2008125891A3 Pyrimidinyl-piperazines useful as dopamine d3 /d2 receptor ligands |
| 01/08/2009 | WO2008122440A3 Remedy for the treatment of cardio-vascular diseases or disorders |
| 01/08/2009 | WO2008119720A8 1-(1-cyclobutyl-4-piperidinyl)-1,3-dihydro-2h-benzimidazol-2-one derivatives which have activity on the m1 receptor and their use in medicine |
| 01/08/2009 | WO2008117117A3 Compositions and method for hair loss prevention |
| 01/08/2009 | WO2008115870A3 Induction and/or maintenance of tumor dormancy by disruption of urokinase plasminogen activator receptor-integrin interaction |
| 01/08/2009 | WO2008115385A3 Piperazine-substituted pyridazinone derivatives useful as glucan synthase inhibitors |
| 01/08/2009 | WO2008114015A3 Isoprenoid compounds, their isolation and use |
| 01/08/2009 | WO2008112701A3 G-substrate for the treatment and prevention of parkinson's disease |
| 01/08/2009 | WO2008112525A8 Treatment of lysosomal storage diseases |
| 01/08/2009 | WO2008109472A4 Nucleic acid compounds for inhibiting pcsk9 gene exprression and uses thereof |
| 01/08/2009 | WO2008109450A4 Nucleic acid compounds for inhibiting id-1 gene expression and uses thereof |
| 01/08/2009 | WO2008109055A8 Cyanopyrrole sulfonamides useful for modulation of the progesterone receptor |
| 01/08/2009 | WO2008102128A3 Pharmaceutical combinations of at least two bronchodilators or of a bronchodilator with a corticosteroid |
| 01/08/2009 | WO2008091740A4 Polyelectrolyte precipitation and purification of antibodies |
| 01/08/2009 | WO2008089389A3 Treatment of cancers with acquired resistance to kit inhibitors |
| 01/08/2009 | WO2008086079A9 Compositions comprising rnai and a neurotrophic factor and uses thereof |
| 01/08/2009 | WO2008080001A3 Compounds and methods for kinase modulation, and indications therefor |
| 01/08/2009 | WO2008074450A3 Non-peptidic renin inhibitors nitroderivatives |
| 01/08/2009 | WO2008063727A3 Combination therapy for treatment of viral infections |
| 01/08/2009 | WO2008063548A3 5, 6, or 7-substituted-s- (hetero)arylisoquinolinamine derivatives as antitumor agents |
| 01/08/2009 | WO2008057254A3 Tricyclic compounds as matrix metalloproteinase inhibitors |
| 01/08/2009 | WO2008049113A3 Generating an immune response by inducing cd40 and pattern recognition receptors |
| 01/08/2009 | WO2008040441A3 Silicon derivatives for pet imaging |
| 01/08/2009 | WO2008039863A3 Composition comprising a melanocortin receptor (mcr) modulating agent alone or in combination with a second neurogenic agent for treating nervous system disorders |
| 01/08/2009 | WO2008033745A3 Fused bicyclic pyrimidines as ptk inhibitors containing a zinc binding moiety |
| 01/08/2009 | WO2008017331A3 Peroral drug form comprising dienogest and ethinyl estradiol for contraception |
| 01/08/2009 | WO2008012338A3 Pharmaceutical formulations comprising azelastine and a corticosteroid for the treatment of inflammatory or allergic conditions |
| 01/08/2009 | WO2008009210A8 Optical pure dihydropyrimidine compounds, their uses in the manufacture of a medicamnent for the treatment or the prevention of virosis diseases |
| 01/08/2009 | WO2008008155A3 Small molecule modulators of p53 family signaling |
| 01/08/2009 | WO2008005287A8 Pharmaceutical compositions comprising a combination of piperidinoalkanol and decongestant |
| 01/08/2009 | WO2007134827A8 5-phenyl-thiaz0l-2-yl-urea derivatives and use as pi3 kinase inhibitors |